Home / Netherlands / Pharming Group N.V.
Pharming Group N.V.
Short position disclosed on September 22, 2026.
Evolution of the disclosed total
January 23, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 1.43% | +0.71 pt | September 22, 2026 | |
| Two Sigma Investments, LP | 1.28% | new | September 1, 2026 | |
| Capstone Volatility Master (Cayman) Limited | 0.72% | -0.31 pt | September 11, 2026 | |
| D. E. Shaw & Co., L.P. | 0.65% | new | September 18, 2026 | |
| Lazard Asset Management LLC | 0.60% | +0.02 pt | September 22, 2026 | |
| Walleye Capital LLC | 0.59% | new | September 22, 2026 | |
| Whitebox Advisors LLC | 0.58% | new | June 3, 2026 | |
| Spark Investment Management LLC | 0.52% | new | June 19, 2026 | |
| AQR Capital Management, LLC | 0.51% | new | September 11, 2026 | |
| Jupiter Asset Management Ltd. | 0.51% | new | September 11, 2026 |
In the United States PHGUF (OTC): 12,050,531 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Pharming Group N.V. Titelia
Get the moves on Pharming Group N.V. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| May 8, 2018 | Marshall Wace LLP | 1.27% | |
| May 7, 2018 | Marshall Wace LLP | 1.39% | |
| May 2, 2018 | Marshall Wace LLP | 1.45% | |
| April 30, 2018 | PDT Partners, LLC | 1.45% | |
| April 27, 2018 | Marshall Wace LLP | 1.58% | |
| April 27, 2018 | PDT Partners, LLC | 1.39% | |
| April 24, 2018 | PDT Partners, LLC | 1.23% | |
| April 18, 2018 | Marshall Wace LLP | 1.69% | |
| April 18, 2018 | PDT Partners, LLC | 1.11% | |
| April 17, 2018 | Marshall Wace LLP | 1.71% | |
| April 16, 2018 | PDT Partners, LLC | 1.04% | |
| April 10, 2018 | PDT Partners, LLC | 0.91% | |
| April 6, 2018 | Marshall Wace LLP | 1.65% | |
| April 5, 2018 | Marshall Wace LLP | 1.74% | |
| April 5, 2018 | PDT Partners, LLC | 0.83% | |
| April 4, 2018 | Marshall Wace LLP | 1.87% | |
| March 20, 2018 | Marshall Wace LLP | 1.99% | |
| March 19, 2018 | Marshall Wace LLP | 2.04% | |
| March 15, 2018 | Marshall Wace LLP | 2.17% | |
| March 9, 2018 | PDT Partners, LLC | 0.75% | |
| March 5, 2018 | Marshall Wace LLP | 2.25% | |
| March 1, 2018 | Marshall Wace LLP | 2.15% | |
| February 27, 2018 | Marshall Wace LLP | 2.03% | |
| February 23, 2018 | Marshall Wace LLP | 1.99% | |
| February 20, 2018 | GSA Capital Partners LLP | 0.49% | |
| February 19, 2018 | Marshall Wace LLP | 2.05% | |
| February 16, 2018 | GSA Capital Partners LLP | 0.51% | |
| February 14, 2018 | Marshall Wace LLP | 1.95% | |
| February 14, 2018 | PDT Partners, LLC | 0.61% | |
| February 9, 2018 | Marshall Wace LLP | 1.60% | |
| February 8, 2018 | Marshall Wace LLP | 1.23% | |
| February 7, 2018 | Marshall Wace LLP | 1.38% | |
| February 6, 2018 | Marshall Wace LLP | 1.47% | |
| February 5, 2018 | Marshall Wace LLP | 1.34% | |
| February 2, 2018 | Marshall Wace LLP | 1.24% | |
| January 31, 2018 | Marshall Wace LLP | 1.12% | |
| January 30, 2018 | Marshall Wace LLP | 1.03% | |
| January 29, 2018 | Marshall Wace LLP | 0.96% | |
| January 24, 2018 | Marshall Wace LLP | 0.81% | |
| January 24, 2018 | PDT Partners, LLC | 0.50% | |
| January 23, 2018 | Marshall Wace LLP | 0.77% | |
| January 22, 2018 | Marshall Wace LLP | 0.62% | |
| January 24, 2014 | Susquehanna International Holdings LLC | 0.16% | |
| January 23, 2014 | Susquehanna International Holdings LLC | 0.50% |
Download 1144 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.59% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Imcd N.V. 4.75% of the capital sold short
- Fugro N.V. 3.69% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- NSI N.V. 2.59% of the capital sold short
- PostNL N.V. 2.04% of the capital sold short
- Alfen N.V. 1.98% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
- Avantium N.V. 1.39% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Pharming Group N.V., source AFM, data as at September 22, 2026, https://www.quivad.com/action/pharming-group-n-v?page=23